medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2013, Number 4

<< Back Next >>

Rev Invest Clin 2013; 65 (4)

Aspectos inmunopatológicos de la tuberculosis meníngea

Hernández-Pando R, Soto-Hernández JL, Salinas-Lara C

Language: Spanish
References: 39
Page: 349-356
PDF size: 351.45 Kb.


Text Extraction

No abstract


REFERENCES

  1. Rook GAW, Hernández Pando R. The pathogenesis of tuberculosis. Annual Rev Microbiol 1996; 50: 259-84.

  2. World Health Organization. TB-a global emergency. WHO report on the TB endemics. Geneva: WHO; 1994.

  3. Garg RK. Tuberculosis of the central nervous system. Postgrad Med J 1999; 75(881): 133-40.

  4. Katti MK. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med Sci Monit 2004; 10(9): RA215-RA229.

  5. Maltezou HC, Spyridis P, Kafetzis DA. Extrapulmonary tuberculosis in children. Arch Dis Child 2000; 83: 342-6.

  6. Ogawa SK, Smith MA, Brennessel DJ, Lowry FD. Tuberculous meningitis in an urban medical centre. Medicine 1987; 66: 317-26.

  7. Jaffe IP. Tuberculous meningitis in childhood. Lancet 1982; 1: 738.

  8. Parsons M. Tuberculous meningitis. Oxford: Oxford University Press; 1979, p. 2-4.

  9. Rock RB, Olin M, Baker C, Molitor T, Peterson P. Central Nervous System tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21: 243-61.

  10. Katti M. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med Sci Monit 2004: 10: RA215-RA229.

  11. Grag RK. Classical diseases revisted: tuberculosis of the central nervous system. Postgrad Med J 1999; 75: 133-40.

  12. Mc Adam AJ, Sharpe AH. Phatologic Basis of Disease. Kumar- Abbas-Fausto. Infectious Diseases. Chap. 8. 2005, p. 381-8.

  13. Rich AR, McCordock HA. The pathogenesis of tubercular meningitis. Bull John Hopkins Hosp 1933; 52: 5-13.

  14. Tsenova L, Sokol K, Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protect rabbits from mycobacterial meningitis-associated death. J Infect Dis 1998; 177(6): 1563-72.

  15. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA 1999; 96(10): 5657-62.

  16. van Well GT, Wieland CW, Florquin S, Roord JJ, van der Poll T, van Furth AM. A new murine model to study the pathogenesis of tuberculous meningitis. J Infect Dis 2007; 195(5): 694–7.

  17. Wu HS, Kolonoski P, Chang YY, Bermudez LE. Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice. Infect Immun 2000; 68(5): 2979-84.

  18. Bolin CA, Whipple DL, Khanna KV, Risdhal JM, Peterson PK, Molitor TW. Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J Infect Dis 1997; 176(6): 1559-66.

  19. Hernandez-Pando R, Aguilar D, Cohen I, Guerrero M, Ribon W, Acosta P, et al. Specific bacterial genotype of Mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model. Tuberculosis (Edinb) 2010; 90(4): 268-77.

  20. Huang SH, Jong AY. Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier. Cell Microbiol 2001; 3(5): 277-87.

  21. Jain SK, Paul-Satyassela M, Lamichhane G, Kim KS, Bishai WR. Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. J Infect Dis 2006; 193(9): 1287-95.

  22. Arvanitakis Z, Long RL, Herschfield ES, Manfreda J, Kabani A, Kunimoto D, et al. M. tuberculosis molecular variation in CNS infection: Evidence for strain-dependent neurovirulence. Neurology 1998; 50(6): 1827-32.

  23. Menozzi F, Biochoff R, Fort E, Brennan M, Locht C. Molecular characterization of the mycobacterial heparin binding hemaglutanina mycobacterial adhesin. Proc Natl Acad Sci USA 1998; 95: 12625-30.

  24. Soares de Lima C, Zulianello L, Melo Marques M, Kim H, Portugal MI, Antunes SL, et al. Mapping the laminin-binding and adhesive domain of the cell surface-associated Hlp/LBP protein from Mycobacterium leprae. Microb Infect 2005; 7: 1097-109.

  25. Castillón-Benavides O. Tuberculosis del sistema nervioso central; patrones de genotipos de Mycobacterium tuberculosis y sus características clínicas. Tesis de Maestría. Sección de Estudios de Posgrado e Investigación. Posgrado en Ciencias Quimicobiológicas. Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional. México 2012.

  26. Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol 2011; 2011: 405310.

  27. Rivas Santiago B, Sada E, Tsutsumi V, Aguilar Leon D, Leon Contreras JC, Hernández Pando R. Expression of β-defensins during the course of experimental tuberculosis infection. J Infect Dis 2006; 194: 697-701.

  28. Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exits strategy? Nat Rev Microbiol 2010; 8: 668-74.

  29. Rios Barrera V, Campos Peña V, Aguilar Leon D, Lascurain Ledesma R, Meraz Rios MA, Moreno J, Figueroa GV, et al. Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: Their relationship to mycobacterial virulence. Eur J Immunol 2006; 36: 345-53.

  30. Hernández-Pando R, Orozco H, Aguilar D. Factors that deregulate the protective immune response in tuberculosis. Arch Immunol Ther Exp (Warsz) 2009; 57(5): 355-67.

  31. Mastroianni CM, Paoletti F, Lichtner M, D’Agostino C, Vullo V, Delia S. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol 1997; 84: 171-6.

  32. Babu GN, Kumar A, Kalita J, Misra UK. Pro-inflammatory cytokines levels in the serum and cerebrospinal fluid of tubercu- lous meningitis patients. Neuroscience Lett 2008; 436: 48-51.

  33. Hendrix S, Nitsch R. The role of T helper cells in neuroprotection and regeneration. J Neuro Immunol 2007; 184: 100-12.

  34. 34 . Schoeman JF, Fieggen G, Seller N, Mendelson M, Hartzenberg B. Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J Child Neurol 2006; 21: 301-08.

  35. Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, Cheung WC, et al. Risk factors for development of paradoxical response during anti-tuberculous therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003; 22: 597-602.

  36. Conradie F, Foulkes AS, Ive P, Yin X, Roussos K, Glencross DK, Lawrie D, et al. Natural Killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection. J Acquir Immune Defic Syndr 2011; 58(3): 309-18.

  37. Haddow LJ, Dibben O, Moosa MY, Borrow P, Easterbrook PJ. Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2011; 25(9): 1163-74.

  38. de Almeida AS, Fiske CT, Sterling TR, Kalams SA. Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis. Clin Vaccine Immunol 2012; 19(1): 45-52.

  39. Blackmore TK, Manning L, Taylor WJ, Wallis RS. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 2008; 47(10): e83-e85.




2020     |     www.medigraphic.com